TrialNature medicine2026

Povorcitinib for hidradenitis suppurativa: the randomized, double-blind, placebo-controlled STOP-HS1 and STOP-HS2 phase 3 trials.

Martina L Porter et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.